TY  - JOUR
A1  - Muecke, Ralph
A1  - Micke, Oliver
A1  - Schomburg, Lutz
A1  - Kisters, Klaus
A1  - Buentzel, Jens
A1  - Huebner, Jutta
A1  - Kriz, Jan
T1  - Selenium supplementation in radiotherapy patients : do we need to measure selenium levels in serum or blood regularly prior radiotherapy?
T2  - Radiation Oncology
N2  - Considering the review by Puspitasari and colleagues, an additional discussion of the endpoints of the Se supplementation studies described would be helpful. In our view, selenium can safely be given to selenium-deficient cancer patients prior to and during radiotherapy. Therefore, in order to help the radiation oncologist in decision making, we strongly advocate to determine the selenium status prior to and during a potential adjuvant selenium supplementation, e.g. when trying to ease the side-effects of radiation treatment or in the aftercare situation when the selenium status may become insufficient.
KW  - Selenium
KW  - Supplementation
KW  - Clinical studies
KW  - Selenoproteins
KW  - Radiotherapy
Y1  - 2014
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/37182
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-371820
SN  - 1748-717X
N1  - © 2014 Muecke et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
VL  - 9
IS  - 289
PB  - BioMed Central
CY  - London
ER  -